Our Latest News

On this page, find out the latest news about KOELIS®, our innovations, prostate biopsy and many other prostate cancer’s related topics. For meeting up with our team, you can either contact us or join one of our next programmed event.

KOELIS declaration about Covid-19

COVID-19 Measures and continuity at Koelis As all know, the World is hit by a health and economic pandemia.Koelis with offices and employees in France, USA, Hong Kong. We have customers, suppliers, partners, counsels, investors, on all continents. Today we want to express our absolute priority in protecting all of them while ensuring the continuity…

Details

KOELIS & InnovaHealth Partners Partnership

KOELIS partnership with InnovaHealth Partners KOELIS adventures take a new turn! The French/US Company who is a global leading actor in prostate cancer fusion biopsy and focal therapy, is proud and happy to announce a growth equity investment by InnovaHealth Partners. Congrats to employees, partners, clients! Download Press Release (FR)Download Press Release (EN)

Details

KOELIS to Present State-of-the-Art Technology at AUA19

KOELIS to Present State-of-the-Art Technology for Precise Prostate Cancer Management at Major Urological Meeting Download the Press Release Leading prostate cancer device company to attend the American Urological Association Annual Meeting at booth #2432 Meylan, France and Auburndale, MA, April 29, 2019 – KOELIS, the inventor of Organ-Based Tracking fusion technology (OBT Fusion®) for the…

Details

KOELIS presented its new solutions at EAU 2019

New solutions at EAU 2019   KOELIS proudly participated to the 34th Annual EAU Congress in Barcelona from the 15th to the 19th of March 2019. The prostate care company presented the reliable, user-friendly and all-in-one, KOELIS Trinity® fusion biopsy system that enables precisely and individually manage prostate cancer, from targeted diagnosis to targeted treatment…

Details

KOELIS receives the Bref Eco award for the MIRAS project

KOELIS awarded Lab Meeting Prize Last 20th November, KOELIS received the Lab Meeting Prize for the MIRAS project, launched by Minalogic, the global innovation cluster for digital technologies in Auvergne-Rhone Alpes. The 13th Edition of the Bref Eco contest awarded 7 innovative projects among more than 70 that were presented. The MIRAS (Multi-Image & Robot…

Details

KOELIS in the Top 10 Medical Imaging Solution Providers 2018

KOELIS is in the top 10 Medical Imaging Solution Providers 2018! “Health innovation as a passion” – These are the words that better represents our commitment and passion. At KOELIS, our mission is to provide clinicians with quality control at every step of the prostate cancer management. We are constantly innovating to bring the most…

Details

KOELIS, present it’s integrated solution at JUA Congress – Japan

From 19th to 22nd April, KOELIS proudly participated with its Japanese partner AMCO to the 106th Annual Meeting of the Japanese Urological Association that was held in Kyoto The Prostate Care company introduced its innovative solutions that are transforming current prostate cancer management paradigms: KOELIS Trinity®, KOELIS MrDraw®, KOELIS Apollo®, KOELIS Katty®. Simultaneously to the…

Details

PRECISION Clinical Study confirms Targeted Biopsy combined with Medical Imaging Improves Accuracy and Efficiency of Diagnosis

Results of the PRECISION international clinical trial published in the New England Journal of Medicine confirm KOELIS’ approach KOELIS announces its contribution to the PRECISION* scientific study, which aims to assess the benefits of Magnetic Resonance Imaging (MRI) for the diagnosis of prostate cancer, headed by the University College of London. The results of the…

Details

KOELIS receives the World Innovation Contest Prize for KATTY

Last week, KOELIS received the award of the Concours Mondial de l’Innovation Phase 2 from Anne Lauvergeon, President of the Commission innovation 2030, Nicolas Dufourcq, General Director of Bpifrance, and Guillaume Boudy, General Secretary of SGPI. Antoine Leroy, KOELIS President and Founder collected the prize in the “Personalized Medicine” category for the Prostate Targeted Treatment program KATTY.   The ambitious project…

Details